We are live on ! Find out more
Hillman Capital Management

Hillman Capital Management Portfolio holdings

AUM $134M Turnover 10.53%
1-Year Est. Return 9.38%
This Fund
S&P 500
This Quarter Est. Return
+4.36%
1 Year Est. Return
+9.38%
3 Year Est. Return
+32.74%
5 Year Est. Return
+29.78%
10 Year Est. Return
–
AUM
$134M
AUM Growth
-$4.41M
Cap. Flow
-$8.39M
Cap. Flow %
-6.28%
Top 10 Hldgs %
37%
Holding
57
New
3
Increased
19
Reduced
31
Closed
3
Avg Time Held
3.5 years
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
2.7 years

Top Buys

Rank Stock Value
1
CSGP icon
CoStar Group
CSGP
+$2.12M
2
NKE icon
Nike
NKE
+$1.3M
3
AKAM icon
Akamai
AKAM
+$768K
4
ORCL icon
Oracle
ORCL
+$726K
5
HRL icon
Hormel Foods
HRL
+$434K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$5.74M
2
WST icon
West Pharmaceutical
WST
+$2.55M
3
VEEV icon
Veeva Systems
VEEV
+$1.57M
4
BAX icon
Baxter International
BAX
+$976K
5
CRM icon
Salesforce
CRM
+$750K

Sector Composition

Rank Sector Weight
1 Healthcare 25.17%
2 Consumer Staples 19.51%
3 Technology 17.41%
4 Communication Services 9.96%
5 Materials 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
WBD icon
1
DELISTED
Warner Bros
WBD
$5.84M 4.37%
188,692
-1,294
-0.7% -$35.9K
2021 Q2
21 quarters
IFF icon
2
International Flavors & Fragrances
IFF
$19.9B
$5.2M 3.89%
62,335
-540
-0.9% -$44.6K
2023 Q2
13 quarters
BIIB icon
3
Biogen
BIIB
$36.9B
$5.17M 3.87%
22,902
-1,091
-5% -$231K
2019 Q4
27 quarters
PFE icon
4
Pfizer
PFE
$156B
$4.95M 3.7%
173,430
-1,180
-0.7% -$31.4K
2023 Q4
11 quarters
EL icon
5
Estee Lauder
EL
$36B
$4.91M 3.67%
52,966
+2,740
+5% +$249K
2023 Q4
11 quarters
MSFT icon
6
Microsoft
MSFT
$3.6T
$4.86M 3.63%
9,469
-827
-8% -$382K
2013 Q2
53 quarters
KMX icon
7
CarMax
KMX
$6.82B
$4.73M 3.54%
85,891
-5,494
-6% -$320K
2022 Q2
17 quarters
BAX icon
8
Baxter International
BAX
$13.1B
$4.71M 3.52%
196,312
-39,720
-17% -$976K
2023 Q3
12 quarters
DD icon
9
DuPont de Nemours
DD
$19.3B
$4.6M 3.44%
35,435
-2,310
-6% -$314K
2019 Q4
27 quarters
BF.B icon
10
Brown-Forman Class B
BF.B
$13.7B
$4.5M 3.36%
171,742
-772
-0.4% -$20.8K
2024 Q4
7 quarters
GSK icon
11
GSK
GSK
$95.7B
$4.43M 3.31%
91,962
-421
-0.5% -$21.5K
2020 Q4
23 quarters
ZBH icon
12
Zimmer Biomet
ZBH
$19.1B
$4.38M 3.27%
49,280
-4,663
-9% -$442K
2021 Q3
20 quarters
KHC icon
13
Kraft Heinz
KHC
$30.1B
$4.13M 3.09%
181,952
-14,542
-7% -$366K
2019 Q4
27 quarters
ADBE icon
14
Adobe
ADBE
$84.7B
$4.1M 3.07%
17,095
-193
-1% -$48.3K
2024 Q2
9 quarters
BA icon
15
Boeing
BA
$124B
$3.99M 2.98%
21,439
-135
-0.6% -$28.9K
2020 Q2
25 quarters
NKE icon
16
Nike
NKE
$48.9B
$3.91M 2.93%
110,532
+32,319
+41% +$1.3M
2024 Q1
10 quarters
FISV icon
17
Fiserv
FISV
$29.7B
$3.53M 2.64%
78,210
-246
-0.3% -$12.6K
2025 Q3
4 quarters
CPB icon
18
Campbell's
CPB
$7.11B
$3.48M 2.6%
175,483
+14,440
+9% +$320K
2024 Q1
10 quarters
EFA icon
19
iShares MSCI EAFE ETF
EFA
$71.4B
$3.35M 2.51%
32,288
+545
+2% +$57.7K
2019 Q4
27 quarters
TSM icon
20
TSMC
TSM
$1.65T
$2.57M 1.93%
5,644
+36
+0.6% +$15.3K
2024 Q3
8 quarters
BDX icon
21
Becton Dickinson
BDX
$58B
$2.55M 1.91%
14,265
-973
-6% -$169K
2020 Q1
26 quarters
DIS icon
22
Walt Disney
DIS
$202B
$2.5M 1.87%
23,787
-1,598
-6% -$164K
2022 Q4
15 quarters
BMY icon
23
Bristol-Myers Squibb
BMY
$120B
$2.48M 1.85%
39,670
-5,565
-12% -$352K
2024 Q2
9 quarters
AKAM icon
24
Akamai
AKAM
$12.3B
$2.46M 1.84%
23,105
+6,718
+41% +$768K
2025 Q2
5 quarters
VZ icon
25
Verizon
VZ
$193B
$2.44M 1.83%
53,258
-4,005
-7% -$188K
2019 Q4
27 quarters

Similar funds

Hillman Capital Management's Q3 2026 Portfolio in Review

As of Q3 2026, Hillman Capital Management held 57 positions worth $134M, down 3.2% from $138M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Hillman Capital Management withdrew a net $8.39M in Q3 2026, closing 3 positions and reducing 31 holdings. Its most notable exit was CVS Health, an estimated $5.74M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, Hillman Capital Management opened a new position in Hormel Foods worth $371K.

  • Hillman Capital Management's largest Q3 2026 buy was Hormel Foods: 18,606 shares worth $371K.
  • Hillman Capital Management added most to CoStar Group in Q3 2026, an estimated $2.12M increase.
  • Hillman Capital Management's biggest Q3 2026 reduction was Veeva Systems, cutting an estimated $1.57M.
  • Hillman Capital Management fully exited CVS Health in Q3 2026, selling an estimated $5.74M.
  • Hillman Capital Management's ten largest holdings make up 37% of its $134M portfolio in Q3 2026.
  • Hillman Capital Management opened 3 new positions and closed 3 in Q3 2026.
  • Hillman Capital Management's portfolio value fell 3.2% quarter-over-quarter to $134M.

Based on Hillman Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.